Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II
about
RTEL1 tagging SNPs and haplotypes were associated with glioma developmentHigh frequency of the X-chromosome inactivation in young female patients with high-grade gliomaGlioma Cells in the Tumor Periphery Have a Stem Cell PhenotypeInsights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.MicroRNA-21 expression is associated with overall survival in patients with gliomaSchwannomas exhibit distinct size-dependent gene-expression patterns.
P2860
Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Expression and clinical signif ...... fuse astrocytomas WHO grade II
@en
type
label
Expression and clinical signif ...... fuse astrocytomas WHO grade II
@en
prefLabel
Expression and clinical signif ...... fuse astrocytomas WHO grade II
@en
P2093
P2860
P356
P1433
P1476
Expression and clinical signif ...... fuse astrocytomas WHO grade II
@en
P2093
Rosilin K Varughese
Stein Sundstrøm
Sverre H Torp
Tove Lind-Landström
P2860
P2888
P356
10.1186/1746-1596-8-67
P577
2013-04-24T00:00:00Z
P5875
P6179
1005747975